期刊文献+

依那普利对大鼠肝纤维化的预防和治疗作用 被引量:3

Preventive and therapeutic effects of enalapril on liver fibrosis in rats
下载PDF
导出
摘要 目的:探讨血管紧张素转化酶抑制剂(ACEI)依那普利(Ena) 对四氯化碳(CCl4)诱导的大鼠实验性肝纤维化的预防和治疗作用. 方法:以CCl4诱导形成大鼠肝实质损伤性肝纤维化模型.大鼠分为对照组、模型组、预防组及治疗组.除对照组外, 其余各组大鼠均sc 400mL/L CCl4橄榄油混合液,每3d/次, 共10wk.预防组同时给予Ena灌胃.治疗组则在造模第5wk 给予Ena灌胃.实验结束后称量肝脾并收取肝组织.通过HE 及Masson三色染色对肝组织炎症及纤维化程度进行评价,通过透射电镜观察肝细胞超微结构. 结果:用药后,与对照组相比,模型组、Ena预防及治疗组体质量均显著下降(P<0.01).与模型组相比,Ena预防及治疗组大鼠肝脾指数均显著降低(P<0.01),Ena高剂量预防及高剂量治疗组均显著改善肝组织炎症和纤维化程度(P<0.01).通过电镜观察肝细胞,Ena高剂量预防及高剂量治疗组肝细胞损害较模型组明显减轻. 结论:依那普利对CCl4诱导的大鼠实验性肝纤维化有良好的预防和治疗作用. AIM: To study the effects of angiotensin-converting enzyme inhibitor, enalapril, on the extent of liver fibrosis in experimental fibrotic rats induced by carbon tetrachloride (CCl4) METHODS: Liver fibrosis in rats was induced by CCI4. Rats were assigned into control group, model group, prevention groups and treatment groups. Except for rats in control group, all rats were given subcutaneous injection of 400 mL/L CCI4, once every 3 days for 10 weeks. Rats in prevention groups were also given enalapril via gastrogavage. But rats in treatment groups were given enalapril from the fifth week to the end via gastrogavage. At the end of tenth week, livers and spleens were measured and specimens of liver were stored. The extent of liver inflammation and fibrosis was evaluated with HE and Masson staining. We also observed the ultrastructures of hepatocytes under electron microscope. RESULTS: After using enalapril, the body weights of model group, enalapril prevention groups and enalapril treatment groups decreased significantly as compared with that of control group (P<0.01). Compared with model group, the liver and spleen indexes of enalapril prevention and treatment groups decreased significantly (P <0.01), enalapril prevention and treatment groups of higher dose considerablely attenuated the extent of liver inflammation and fibrosis (P<0.01). The extent of hepatotic injury in enalapril prevention and treatment groups of higher dose decreased significantly than that of model group under electron microscope. CONCLUSION: Enalapril has better preventive and therapeutic effects on experimental liver fibrosis in rats induced by CCl4.
作者 柳怿 李继强
出处 《世界华人消化杂志》 CAS 2004年第9期2119-2122,共4页 World Chinese Journal of Digestology
  • 相关文献

参考文献30

  • 1Gross V, Obst M, Luft FC. Insights into angiotensin Ⅱ receptor function through AT2 receptor knockout mice. Acta Physiol Scand 2004;181:487-494.
  • 2Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin Ⅱ-induced target organ damage and prevention. Cardiovasc Res 2004;61:663-670.
  • 3Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr. Matrix metalloproteinases: pathways of induction by bioactiv emolecules. Heart Fail Rev 2004;9:53-61.
  • 4Campbell DJ. Renin-angiotensin system inhibition: how much is too much of a good thing. Int Med J 2002;32:616-620.
  • 5Wayne A, Noble BN. Maximizing hemodynamic-independent effects of angiotensin Ⅱ antagonists in fibrotic diseases. Seminars Nephrol 2001;21:563-572.
  • 6Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD,Crawford DH, Shorthouse C, Purdie DM, Jonsson JR. Host genetic factors influence disease progression in chronic hepatitisc. Hepatology 2000;31:828-833.
  • 7Rockey DC. Vasoactive agents in intrahepatic portal hypertention and fibrogenesis: implications for therapy. Gastroenterology 2000;118:1261-1265.
  • 8Tokuda K,Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T. Pres-sure-independent effects of angiotensinⅡ on hypertensive myocardial fibrosis. Hypertension 2004;43:499-503.
  • 9Su~n Y, Zhang J, Lu L, Becligian MP, Robinson AD, Weber KT.Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. J Lab Clin Med 2004;143:41-51.
  • 10Onishi K, Dohi K, Koji T, Funabiki K, Kitamura T, Imanaka-Yoshida K, Ito M, Nobori T, Nakano T. Candesartan prevents myocardial fibrosis during progression of congestive heart failure. J Cardiovasc Pharmacol 2004;43:860-867.

同被引文献49

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部